Construction and application of a Rh-Pt DNA metalloinsertor conjugate

Inorganic Chemistry

Volumn 53, Issue 15, 2014, Pages 7812-7814

  Weidmann, Alyson G ^a   Barton, Jacqueline K ^a  

^a California Institute of Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE INHIBITOR; CISPLATIN; DNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; OXALIPLATIN; PLATINUM COMPLEX; RHODIUM;

ATOMIC ABSORPTION SPECTROMETRY; BASE MISPAIRING; CHEMISTRY; HCT116 CELL LINE; HUMAN; SYNTHESIS;

ANTINEOPLASTIC AGENTS; BASE PAIR MISMATCH; CASPASE INHIBITORS; CISPLATIN; DNA; HCT116 CELLS; HUMANS; ORGANOPLATINUM COMPOUNDS; POLY(ADP-RIBOSE) POLYMERASE INHIBITORS; RHODIUM; SPECTROPHOTOMETRY, ATOMIC;

EID: 84905454374     PISSN: 00201669     EISSN: 1520510X     Source Type: Journal    
DOI: 10.1021/ic501509x     Document Type: Article

References (21)

1. Wang, D.; Lippard, S. J. Nature Rev. Drug Discovery 2005, 4, 307
2. Arzimanoglou, I. I.; Gilbers, F.; Barber, H. R. K. Cancer 1998, 82, 1808-1820
3. Lawes, D. A.; SenGupta, S.; Boulos, P. B. Eur. J. Surg. Oncol. 2003, 29, 201-212
4. Aebi, S.; Fink, D.; Gordon, R.; Kim, H. K.; Zheng, H.; Fink, J. L.; Howell, S. B. Clin. Cancer Res. 1997, 3, 1763-1767
5. Ibrahim, A.; Hirschfeld, S.; Cohen, M. H.; Griebel, D. J.; Williams, G. A.; Pazdur, R. Oncologist 2004, 9, 8-12
6. Jackson, B. A.; Barton, J. K. J. Am. Chem. Soc. 1997, 119, 12986
7. Ernst, R. J.; Song, H.; Barton, J. K. J. Am. Chem. Soc. 2009, 131, 2359
8. Ernst, R. J.; Komor, A. C.; Barton, J. K. Biochemistry 2011, 50, 10919-10928
9. Komor, A. C.; Schneider, C. J.; Weidmann, A. G.; Barton, J. K. J. Am. Chem. Soc. 2012, 134, 19223-19233
10. Wisnovsky, S. P.; Wilson, J. J.; Radford, R. J.; Pereira, M. P.; Chan, M. R.; Laposa, R. R.; Lippard, S. J.; Kelley, S. O. Chem. Biol. 2013, 20, 1323-1328
11. Woynarowski, J. M.; Faivre, S.; Herzig, M. C.; Arnett, B.; Chapman, W. G.; Trevino, A. V.; Raymond, E.; Chaney, S. G.; Vaisman, A.; Varchenko, M.; Juniewicz, P. E. Mol. Pharmacol. 2000, 58, 920-927
12. Jackson, B. A.; Barton, J. K. Biochemistry 2000, 39, 6176-6182
13. Pierre, V. C.; Kaiser, J. T.; Barton, J. K. Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 429-434
14. Zeglis, B. M.; Pierre, V. C.; Barton, J. K. Biochemistry 2009, 48, 4247-4253
15. Brabec, V.; Leng, M. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 5345
16. Koi, M.; Umar, A.; Chauhan, D. P.; Cherian, S. P.; Carethers, J. M.; Kunkel, T. A.; Boland, C. R. Cancer Res. 1994, 54, 4308
17. Eckford, P. D. W.; Sharom, F. J. Chem. Rev. 2009, 109, 2989
18. DPQ = 3,4-dihydro-5[4-(1-piperindinyl)butoxy]-1(2H)-isoquinoline. See: Costantino, G.; Macchiarulo, A.; Camaioni, E.; Pellicciari, R. J. Med. Chem. 2001, 44, 3786-3794
19. By irreversibly binding to the active site of caspases, Z-VAD-FMK inhibits apoptosis. See: Vandenabeele, P.; Vanden Berghe, T.; Festjens, N. Sci. STKE 2006, 358, pe44
20. Siddik, Z. H. Oncogene 2003, 22, 7265
21. Arango, D.; Wilson, A. J.; Shi, Q.; Corner, G. A.; Arañes, M. J.; Nicholas, C.; Lesser, M.; Mariadason, J. M.; Augenlicht, L. H. Br. J. Cancer 2004, 91, 1931